In The News Posted December 13, 2019 Share Posted December 13, 2019 MILFORD, Mass., Dec. 13, 2019 /PRNewswire/ -- Reprieve Cardiovascular®, a pioneering medical device company focused on improving outcomes for patients suffering from acute decompensated heart failure (ADHF), today announced the results of the first-in-human clinical trial with the... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.